Quality of Life Among Survivors of Hodgkin Lymphoma
| Status: | Completed |
|---|---|
| Conditions: | Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/28/2016 |
| Start Date: | May 2005 |
| End Date: | April 2016 |
A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma
The purpose of this study is to collect information on the long-term side effects of
treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin
Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma
survivors' health and quality of life.
treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin
Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma
survivors' health and quality of life.
Inclusion Criteria:
- Biopsy-proven HL Participation in IRB-approved protocols for the first-line treatment
of HL between 1975-2000 (IRB #75-104, #75-103, #79-17, #81-103, #90-44, #91-69).
- English speaking
Exclusion Criteria:
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
